Alterity Therapeutics Limited (ATH.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 4.01 Million | 3.91 Million | 5.12 Million | 4.33 Million | - | 108.53 Thousand |
| Cost of Revenue | 214.3 Thousand | 285.06 Thousand | 364.66 Thousand | 360.02 Thousand | 112.42 Thousand | 29.69 Thousand |
| Gross Profit | 3.8 Million | 3.63 Million | 4.75 Million | 3.97 Million | -112.42 Thousand | 78.84 Thousand |
| Operating Expenses | 23.4 Million | 17.34 Million | 17.53 Million | 19.3 Million | 10.06 Million | 12.47 Million |
| Selling, General and Administrative Expenses | 4.76 Million | 5.03 Million | 5.51 Million | 6.87 Million | 3.33 Million | 4.27 Million |
| Research and Development Expenses | 18.64 Million | 13.19 Million | 14.74 Million | 12.28 Million | 10.09 Million | 12.98 Million |
| Other Expenses | - | -282.96 Thousand | -364.66 Thousand | -360.02 Thousand | -3.36 Million | -4.78 Million |
| Cost and Expenses | 23.62 Million | 17.63 Million | 17.9 Million | 19.66 Million | 10.06 Million | 12.47 Million |
| Operating Income | -19.6 Million | -14.63 Million | -15.5 Million | -15.17 Million | -10.41 Million | -12.71 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 46.08 Thousand | 104.45 Thousand | 70 Thousand | -4.12 Million | -362.18 Thousand | -376.03 Thousand |
| Earnings before Tax | -19.07 Million | -13.7 Million | -12.77 Million | -15.3 Million | -10.05 Million | -12.33 Million |
| Net Income | -19.12 Million | -13.8 Million | -12.84 Million | -15.3 Million | -9.69 Million | -11.96 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Weighted Average Shares Outstanding | 3.64 Billion | 2.42 Billion | 2.4 Billion | 1.69 Billion | 894.87 Million | 615.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.64 Billion | 2.42 Billion | 2.4 Billion | 1.69 Billion | 894.87 Million | 615.77 Million |
| Gross Margin | 0.95 | 0.93 | 0.93 | 0.92 | - | 0.73 |
| EBIT Margin | -4.87 | -3.73 | -3.02 | -3.49 | - | -116.86 |
| Profit Margin | -4.76 | -3.53 | -2.51 | -3.53 | - | -110.21 |
| EBITDA | -19.57 Million | -17.51 Million | -17.39 Million | -19.36 Million | -13.34 Million | -12.76 Million |
| Earnings Before Tax Margin | -4.88 | -3.74 | -3.03 | -3.50 | - | -117.14 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 2.11 Million | 1.9 Million | 3.91 Million | 1.53 Million | 2.38 Million |
| Cost of Revenue | 147.52 Thousand | 73.61 Thousand | 73.91 Thousand | 285.06 Thousand | 52.26 Thousand | 49.99 Thousand |
| Gross Profit | -147.52 Thousand | 2.04 Million | 1.82 Million | 3.63 Million | 1.47 Million | 2.33 Million |
| Operating Expenses | 23.47 Million | 15.02 Million | 8.44 Million | 17.34 Million | 7.72 Million | 10.69 Million |
| Selling, General and Administrative Expenses | - | 2.74 Million | 2.08 Million | - | 2.28 Million | 2.93 Million |
| Research and Development Expenses | - | 12.28 Million | 6.36 Million | - | 5.43 Million | 7.76 Million |
| Other Expenses | - | - | - | -282.96 Thousand | - | - |
| Cost and Expenses | 23.62 Million | 15.1 Million | 8.51 Million | 17.63 Million | 7.77 Million | 10.74 Million |
| Operating Income | -23.62 Million | -15.1 Million | -8.51 Million | -14.63 Million | -7.77 Million | -10.74 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -3.97 Million | -2.07 Million | -1.9 Million | 104.45 Thousand | -1.52 Million | -2.28 Million |
| Earnings before Tax | -23.09 Million | -14.68 Million | -8.4 Million | -13.7 Million | -7.3 Million | -10.31 Million |
| Net Income | -19.12 Million | -12.61 Million | -6.5 Million | -13.8 Million | -5.77 Million | -8.03 Million |
| Earnings Per Share Basic | - | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 5.24 Billion | 6.3 Billion | 2.5 Billion | 2.42 Billion | 2.43 Billion | 2.41 Billion |
| Weighted Average Shares Outstanding (Diluted) | 5.24 Billion | 6.3 Billion | 2.5 Billion | 2.42 Billion | 2.43 Billion | 2.41 Billion |
| Gross Margin | - | 0.97 | 0.96 | 0.93 | 0.97 | 0.98 |
| EBIT Margin | - | -7.09 | -4.44 | - | -5.04 | -4.48 |
| Profit Margin | - | -5.96 | -3.42 | -3.53 | -3.77 | -3.37 |
| EBITDA | - | -15.02 Million | -8.44 Million | - | -7.72 Million | -10.69 Million |
| Earnings Before Tax Margin | - | -7.13 | -4.48 | -3.74 | -5.08 | -4.51 |
8920
HI
ZEPP
KRX
BLAND-R
WAAREERTL